The DOI matches its Crossref record; 136 of the 138 references it cites were found in a registry or an index, and 2 are not checked yet.
Liver fibrosis
Open accessAbstract
Liver fibrosis is the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases. Advanced liver fibrosis results in cirrhosis, liver failure, and portal hypertension and often requires liver transplantation. Our knowledge of the cellular and molecular mechanisms of liver fibrosis has greatly advanced. Activated hepatic stellate cells, portal fibroblasts, and myofibroblasts of bone marrow origin have been identified as major collagen-producing cells in the injured liver. These cells are activated by fibrogenic cytokines such as TGF-beta1, angiotensin II, and leptin. Reversibility of advanced liver fibrosis in patients has been recently documented, which has stimulated researchers to develop antifibrotic drugs. Emerging antifibrotic therapies are aimed at inhibiting the accumulation of fibrogenic cells and/or preventing the deposition of extracellular matrix proteins. Although many therapeutic interventions are effective in experimental models of liver fibrosis, their efficacy and safety in humans is unknown. This review summarizes recent progress in the study of the pathogenesis and diagnosis of liver fibrosis and discusses current antifibrotic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The current study amends this fibrocentric concept by demonstrating fibrosis-independent roles for HSCs through RSPO3, regulating critical parameters that affect CLD progression and outcomes, including metabolic hepatocyte functions, liver regeneration and hepatocyte death2,49,50.”
From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [2]
In the citing paper
“In more advanced disease stages, the ECM can replace functional liver parenchyma and thereby contribute to the development of liver cirrhosis, which is characterized by bridging fibrosis, regenerative nodules, and the loss of liver function [230].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · cites this paper as [230]
In the citing paper
“Two of the prototype cytokines responsible for the activation of HSCs during liver injury are the transforming growth factor-β (TGF-β) and the platelet-derived growth factor (PDGF).[3]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,414
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,171
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
Regev, A., Berho, M. E., Jeffers, L. J., Milikowski, C., Molina, E. G., Pyrsopoulos, N., Feng, Z.-Z., Reddy, K. R., & Schiff, E. R. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.06038.x · Cited by 2,078
Xu, D., He, X., Chang, Y., Sun, S., Xu, C., & Lin, J. (2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Imbert‐Bismut, F., Ratziu, V., Piéroni, L., Charlotte, F., Benhamou, Y., & Poynard, T. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04258-6 · Cited by 1,422
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
Forns, X., Ampurdanés, S., Llovet, J. M., Aponte, J. Á. N., Quintó, L., Martínez‐Bauer, E., Bruguera, M., Sánchez-Tapias, J. M., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.36128 · Cited by 1,123
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K. M., Lutz, M., Murray, L. A., Xue, Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20997 · Cited by 1,071
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Roles of TGF-beta in hepatic fibrosis
Gressner, A. M. (2002) · Frontiers in bioscience · doi:10.2741/a812 · Cited by 785
Management of Cirrhosis and Ascites
Ginès, P., Cárdenas, A., Arroyo, V., & Rodés, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035021 · Cited by 768
History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells
Geerts, A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17550 · Cited by 740
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E. (2004) · Hepatology · doi:10.1002/hep.20251 · Cited by 727
Paik, Y.-H., Schwabe, R. F., Bataller, R., Russo, M. P., Jobin, C., & Brenner, D. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50182 · Cited by 651
Self-citationCooperation of Liver Cells in Health and Disease
Kmieć, Z. (2001) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-642-56553-3 · Cited by 645
Evaluation of Liver Fibrosis: A Concise Review
Afdhal, N. H., & Nunes, D. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30110.x · Cited by 614
Projecting future complications of chronic hepatitis C in the United States
Davis, G. L., Albright, J. E., Cook, S. F., & Rosenberg, D. M. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50073 · Cited by 577
Bataller, R. A., Schwabe, R. F., Choi, Y. H., Yang, L., Paik, Y. H., Lindquist, J. N., Qian, T., Schoonhoven, R., Hagedorn, C. H., Lemasters, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18212 · Cited by 566
Self-citationApoptosis: The nexus of liver injury and fibrosis
Canbay, A. E., Friedman, S. L., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20051 · Cited by 536
Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis
Bataller, R. A., & Brenner, D. A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17558 · Cited by 493
Self-citationNADPH oxidase–derived free radicals are key oxidants in alcohol-induced liver disease
Kono, H., Rusyn, I., Yin, M., Gäbele, E., Yamashina, S., Dikalova, A., Kadiiska, M. B., Connor, H. D., Mason, R. P., Segal, B. H., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9020 · Cited by 493
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
Bataller, R. A., Ginès, P., Nicolás, J. M., Görbig, M. N., García-Ramallo, E., Gasull, X., Bosch, J., Arroyo, V., & Rodés, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70368-4 · Cited by 490
Self-citationFibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis
Arthur, M. J. P. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.2.g245 · Cited by 479
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
Kamada, Y., Tamura, S., Kiso, S., Matsumoto, H., Saji, Y., Yoshida, Y., Fukui, K., Maeda, N., Nishizawa, H., Nagaretani, H., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.029 · Cited by 479
Pinzani, M., Gesualdo, L., Sabbah, G. M., & Abboud, H. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114363 · Cited by 477
Issa, R., Zhou, X., Constandinou, C. M., Fallowfield, J. A., Millward‐Sadler, H., Gaça, M. D. A., Sands, E., Suliman, I., Trim, N., & Knorr, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.009 · Cited by 454
Galli, A., Crabb, D. W., Ceni, E., Salzano, R., Mello, T., Svegliati–Baroni, G., Ridolfi, F., Trozzi, L., Surrenti, C., & Casini, A. (2002) · Gastroenterology · doi:10.1053/gast.2002.33666 · Cited by 440
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis☆
Forbes, S. J., Russo, F. P., Rey, V., Burra, P., Rugge, M., Wright, N. A., & Alison, M. R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.025 · Cited by 434
Hammel, P., Couvelard, A., O'Toole, D., Ratouis, A., Sauvanet, A., Fléjou, J. F., Degott, C., Belghiti, J., Bernades, P., Valla, D., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440604 · Cited by 427
Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics
Callewaert, N., Vlierberghe, H. V., Hecke, A. V., Laroy, W., Delanghe, J., & Contreras, R. (2004) · Nature Medicine · doi:10.1038/nm1006 · Cited by 418
Marra, F., Efsen, E., Romanelli, R. G., Caligiuri, A., Pastacaldi, S., Batignani, G., Bonacchi, A., Caporale, R., Laffi, G., Pinzani, M., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.9365 · Cited by 409
Roles of TGF-beta in hepatic fibrosis
Axel, M. G. (2002) · Frontiers in bioscience · doi:10.2741/gressner · Cited by 407
Host genetic factors influence disease progression in chronic hepatitis C
Powell, E. E., Edwards-Smith, C. J., Hay, J. L., Clouston, A. D., Crawford, D. H., Shorthouse, C., Purdie, D. M., & Jonsson, J. R. (2000) · Hepatology · doi:10.1053/he.2000.6253 · Cited by 397
Ikejima, K., Takei, Y., Honda, H., Hirose, M., Yoshikawa, M., Zhang, Y., Lang, T., Fukuda, T., Yamashina, S., Kitamura, T., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.32995 · Cited by 386
II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin
Thurman, R. G. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.4.g605 · Cited by 378
Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats
Dooley, S., Hamzavi, J., Breitkopf, K., Wiercinska, E., Said, H. M., Lorenzen, J., ten Dijke, P., & Gressner, A. M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00666-8 · Cited by 370
Genetic Polymorphisms and the Progression of Liver Fibrosis: A Critical Appraisal
Bataller, R. A., North, K. E., & Brenner, D. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50127 · Cited by 356
Self-citationBataller, R. A., Sancho‐Bru, P., Ginès, P., Lora, J. M., Al-Garawi, A. A., Solé, M., Colmenero, J., Nicolás, J. M., Jiménez, W., Weich, N. S., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00695-4 · Cited by 352
Self-citationRat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture.
Rockey, D. C., Boyles, J. K., Gabbiani, G., & Friedman, S. L. (1992) · PubMed · Cited by 342
Knittel, T. E., Kobold, D., Saile, B., Grundmann, A., Neubauer, K., Piscaglia, F., & Ramadori, G. P. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70407-5 · Cited by 338
Shi, Z., Wakil, A. E., & Rockey, D. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10663 · Cited by 310
Casini, A., Ceni, E., Salzano, R., Biondi, P., Parola, M., Galli, A., Foschi, M., Caligiuri, A., Pinzani, M., & Surrenti, C. (1997) · Hepatology · doi:10.1002/hep.510250218 · Cited by 302
Fas enhances fibrogenesis in the bile duct ligated mouse: A link between apoptosis and fibrosis
Canbay, A. E., Higuchi, H., Bronk, S. F., Taniai, M., Sebo, T. J., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35953 · Cited by 302
Angiotensin-Converting Enzyme Inhibition Attenuates the Progression of Rat Hepatic Fibrosis
Jonsson, J. R., Clouston, A. D., Ando, Y., Kelemen, L., Horn, M. J., Adamson, M., Purdie, D. M., & Powell, E. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25480 · Cited by 296
Liver biopsy: complications and risk factors
Thampanitchawong, P. (2000) · World Journal of Gastroenterology · doi:10.3748/wjg.v5.i4.301 · Cited by 294
Histological course of alcoholic hepatitis
Parés, A. R., Caballería, J., Bruguera, M., Torres, M., & Rodés, J. (1986) · Journal of Hepatology · doi:10.1016/s0168-8278(86)80006-x · Cited by 293
Hepatic Stellate Cells: Unique Characteristics in Cell Biology and Phenotype
Sato, M., Suzuki, S., & Senoo, H. (2003) · Cell Structure and Function · doi:10.1247/csf.28.105 · Cited by 292
DDR2 receptor promotes MMP-2–mediated proliferation and invasion by hepatic stellate cells
Olaso, E., Ikeda, K., Eng, F. J., Xu, L.-M., Wang, L., Lin, H. C., & Friedman, S. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112373 · Cited by 291
Pópper, H., & Udenfriend, S. (1970) · The American Journal of Medicine · doi:10.1016/s0002-9343(70)80135-8 · Cited by 284
Friedman, S. L., Rockey, D. C., McGuire, R. F., Maher, J. J., Boyles, J. K., & Yamasaki, G. (1992) · Hepatology · doi:10.1002/hep.1840150211 · Cited by 284
Benyon, R. C., & Iredale, J. P. (2000) · Gut · doi:10.1136/gut.46.4.443 · Cited by 260
The Role of Smad3 in Mediating Mouse Hepatic Stellate Cell Activation
Schnabl, B., Kweon, Y. O., Frederick, J. P., Wang, X.-F., Rippe, R. A., & Brenner, D. A. (2001) · Hepatology · doi:10.1053/jhep.2001.25349 · Cited by 256
Self-citationDifferentiation and function of Kupffer cells
Naito, M., Hasegawa, G., Ebe, Y., & Yamamoto, T. (2004) · Medical Molecular Morphology · doi:10.1007/s00795-003-0228-x · Cited by 252
Human Hepatic Stellate Cells Express CCR5 and RANTES to Induce Proliferation and Migration
Schwabe, R. F., Bataller, R., & Brenner, D. A. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00215.2003 · Cited by 252
Self-citationBataller, R. A., Paik, Y., Lindquist, J. N., Lemasters, J. J., & Brenner, D. A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.018 · Cited by 251
Self-citationThe role of kupffer cell oxidant production in early ethanol-induced liver disease,
Wheeler, M. D. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00748-1 · Cited by 249
Magness, S. T., Bataller, R. A., Yang, L., & Brenner, D. A. (2004) · Hepatology · doi:10.1002/hep.20427 · Cited by 246
Self-citationPDGF and signal transduction in hepatic stellate cells
Pinzani, M. (2002) · Frontiers in bioscience · doi:10.2741/a875 · Cited by 239
Safadi, R., Ohta, M., Alvarez, C. E., Fiel, M. I., Bansal, M., Mehal, W. Z., & Friedman, S. L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.062 · Cited by 239
Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C
Arthur, M. J. P. (2002) · Gastroenterology · doi:10.1053/gast.2002.33367 · Cited by 238
Contribution of obesity to hepatitis C-related fibrosis progression
Ortiz, V., Berenguer, M., Rayón, J. M., Carrasco, D., & Berenguer, J. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05995.x · Cited by 233
Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Nakatani, T., Tsujinoue, H., Yanase, K., Namisaki, T., Imazu, H., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.35625 · Cited by 229
Takehara, T., Tatsumi, T., Suzuki, T., Rucker, E. B., Hennighausen, L. G., Jinushi, M., Miyagi, T., Kanazawa, Y., & Hayashi, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.019 · Cited by 223
Viñas, O., Bataller, R., Sancho-Bru, P., Ginès, P., Berenguer, C., Enrich, C., Nicolás, J. M., Ercilla, G., Gallart, T., Vives, J., et al. (2003) · Hepatology · doi:10.1002/hep.1840380418 · Cited by 223
Self-citationHepatic fibrogenesis requires sympathetic neurotransmitters
Oben, J. A., Roskams, T., Yang, S., Lin, H., Sinelli, N., Torbenson, M., Smedh, U., Moran, T. H., Li, Z., Huang, J., et al. (2004) · Gut · doi:10.1136/gut.2003.026658 · Cited by 215
Chemokines in liver inflammation and fibrosis
Marra, F. (2002) · Frontiers in bioscience · doi:10.2741/a887 · Cited by 214
Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis
Canbay, A. E., Guicciardi, M. E., Higuchi, H., Feldstein, A. E., Bronk, S. F., Rydzewski, R. M., Taniai, M., & Gores, G. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17740 · Cited by 210
Hepatitis C and liver fibrosis
Schuppan, D., Schulze-Krebs, A., Bauer, M. W., & Hahn, E. G. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401163 · Cited by 209
Portal tract fibrogenesis in the liver
Ramadori, G. P., & Saile, B. (2003) · Laboratory Investigation · doi:10.1038/labinvest.3700030 · Cited by 201
Wanless, I. R., & Shiota, K. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-823104 · Cited by 200
Interactions Between Hepatic Stellate Cells and the Immune System
Maher, J. J. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17555 · Cited by 198
Noninvasive monitoring of patients with chronic hepatitis C
Fontana, R. J., & Lok, A. S.-F. (2002) · Hepatology · doi:10.1053/jhep.2002.36800 · Cited by 196
Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis
Milani, S., Herbst, H., Schuppan, D., Kim, K. Y., Riecken, E. O., & Stein, H. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91307-r · Cited by 192
Transcriptional regulation of hepatic stellate cell activation: Figure 1
Mann, D. A., & Smart, D. E. (2002) · Gut · doi:10.1136/gut.50.6.891 · Cited by 191
Up-regulation of components of the renin-angiotensin system in the bile duct–ligated rat liver
Paizis, G., Cooper, M. E., Schembri, J. M., Tikellis, C., Burrell, L. M., & Angus, P. (2002) · Gastroenterology · doi:10.1053/gast.2002.36561 · Cited by 189
Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis
Canbay, A. E., Guicciardi, M. E., Higuchi, H., Feldstein, A. E., Bronk, S. F., Rydzewski, R. M., Taniai, M., & Gores, G. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317740 · Cited by 188
Hepatic stellate cells and the regulation of liver inflammation
Marra, F. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80327-4 · Cited by 187
Williams, E. J., Benyon, R. C., Trim, N., Hadwin, R. J., Grove, B. H., Arthur, M. J. P., Unemori, E., & Iredale, J. P. (2001) · Gut · doi:10.1136/gut.49.4.577 · Cited by 186
Albanis, E., & Friedman, S. L. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70168-9 · Cited by 184
SOCS1 Is a Suppressor of Liver Fibrosis and Hepatitis-induced Carcinogenesis
Yoshida, T., Ogata, H., Kamio, M., Joo, A., Shiraishi, H., Tokunaga, Y., Sata, M., Nagai, H., & Yoshimura, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031675 · Cited by 184
Liver nbsp fibrosis signals leading to the amplification of the fibrogenic hepatic stellate cell
Rippe, R. A. (2003) · Frontiers in bioscience · doi:10.2741/887 · Cited by 183
Genetic polymorphisms of alcohol metabolizing enzymes
Agarwal, D. P. (2001) · Pathologie Biologie · doi:10.1016/s0369-8114(01)00242-5 · Cited by 182
Sahai, A., Malladi, P., Melin-Aldana, H., Green, R. M., & Whitington, P. F. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00002.2004 · Cited by 181
Interleukin 6/Gp130–Dependent Pathways Are Protective During Chronic Liver Diseases
Streetz, K. L., Tacke, F., Leifeld, L., Wüstefeld, T., Graw, A., Klein, C., Kamino, K., Spengler, U., Kreipe, H. H., Kubicka, S., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50268 · Cited by 168
Cho, J., Hocher, B., Herbst, H., Jia, J., Ruehl, M., Hahn, E. G., Riecken, E. O., & Schuppan, D. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70370-2 · Cited by 167
Yu, C., Wang, F., Jin, C., Huang, X., Miller, D. L., Basilico, C., & McKeehan, W. L. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63522-5 · Cited by 167
Marra, F., Arrighi, M. C., Fazi, M., Caligiuri, A., Pinzani, M., Romanelli, R. G., Efsen, E., Laffi, G., & Geñtilini, P. (1999) · Hepatology · doi:10.1002/hep.510300406 · Cited by 160
Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis
Paizis, G., Gilbert, R. E., Cooper, M. E., Murthi, P., Schembri, J. M., Wu, L. L., Rumble, J. R., Kelly, D. J., Tikellis, C., Cox, A. J., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00146-5 · Cited by 157
NF-kappaB Inhibits Expression of the alpha1(I) Collagen Gene
Rippe, R. A., Schrum, L. W., Stefanovic, B., Solis-Herruzo, J. A., & Brenner, D. A. (1999) · DNA and Cell Biology · doi:10.1089/104454999314890 · Cited by 156
Self-citationSchwabe, R. F., Schnabl, B., Kweon, Y. O., & Brenner, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6812 · Cited by 155
Self-citationJärveläinen, H. A., Orpana, A., Perola, M., Savolainen, V. T., Karhunen, P. J., & Lindros, K. O. (2001) · Hepatology · doi:10.1053/jhep.2001.24236 · Cited by 149
Ueberham, E., Löw, R., Ueberham, U., Schönig, K., Bujard, H., & Gebhardt, R. (2003) · Hepatology · doi:10.1053/jhep.2003.50196 · Cited by 148
Bataller, R. A., Gäbele, E., Schoonhoven, R., Morris, T., Lehnert, M., Yang, L., Brenner, D. A., & Rippe, R. A. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00037.2003 · Cited by 144
Self-citationSchwabe, R. F., Uchinami, H., Qian, T., Bennett, B. L., Lemasters, J. J., & Brenner, D. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0771fje · Cited by 141
Self-citationPeribiliary myofibroblasts in biliary type liver fibrosis
Kinnman, N. (2002) · Frontiers in bioscience · doi:10.2741/a790 · Cited by 139
Mechanisms of Liver Injury: An Overview
Higuchi, H., & Gores, G. J. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479528 · Cited by 133
Thorburn, D., Curry, G., Spooner, R., Spence, E., Oien, K. A., Halls, D. J., Fox, R., McCruden, E. A. B., MacSween, R. N. M., & Mills, P. R. (2002) · Gut · doi:10.1136/gut.50.2.248 · Cited by 133
How can transforming growth factor beta be targeted usefully to combat liver fibrosis?
Shek, F., & Benyon, R. C. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200402000-00001 · Cited by 131
Donaldson, P. T., Agarwal, K., Craggs, A., Craig, W., James, O., & Jones, D. (2001) · Gut · doi:10.1136/gut.48.3.397 · Cited by 123
Noninvasive monitoring of patients with chronic hepatitis C
Fontana, R. J., & Lok, A. S.-F. (2002) · Hepatology · doi:10.1002/hep.1840360708 · Cited by 122
Degoul, F., Sutton, A., Mansouri, A., Cepanec, C., Valla, D. C., Pessayre, D., Fromenty, B., Degott, C., & Beaugrand, M. (2001) · Gastroenterology · doi:10.1053/gast.2001.24051 · Cited by 117
PDGF and signal transduction in hepatic stellate cells
Pinzani, M. (2002) · Frontiers in bioscience · doi:10.2741/pinzani · Cited by 117
Berenguer, M., Prieto, M., Palau, A., Rayón, J. M., Carrasco, D., Juan, F. S., López‐Labrador, F. X., Moreno, R., Mir, J., & Berenguer, J. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50029 · Cited by 114
Natural history of HCV infection
Poynard, T., Ratziu, V., Benhamou, Y., Opolon, P., Cacoub, P., & Bédossa, P. (2000) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.1999.0071 · Cited by 109
Oben, J. A., Yang, S., Lin, H., Ono, M., & Diehl, A. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00232-8 · Cited by 104
Changes in melatonin concentrations during IFN therapy
Uchimura, Y., Uchimura, N., Kumashiro, R., Hattori, A., & Sata, M. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80328-6 · Cited by 95
Wei, H. S. (2000) · World Journal of Gastroenterology · doi:10.3748/wjg.v6.i6.824 · Cited by 93
Leptin and liver fibrosis: A matter of fat
Marra, F. (2002) · Gastroenterology · doi:10.1053/gast.2002.33369 · Cited by 92
Borkham‐Kamphorst, E., Stoll, D., Gressner, A. M., & Weiskirchen, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.153 · Cited by 91
Peribiliary myofibroblasts in biliary type liver fibrosis
Kinnman, N. (2002) · Frontiers in bioscience · doi:10.2741/kinnman · Cited by 82
Mannose-Binding Lectin Polymorphisms in Patients with Hepatitis C Virus Infection
K. Sasaki, A. T. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200750023039 · Cited by 75
Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4).
Wei, H., Li, D., Lu, H., Zhan, Y., Wang, Z., Huang, X., Zhang, J., Cheng, J., & Xu, Q. (2000) · PubMed Central · doi:10.3748/wjg.v6.i4.540 · Cited by 74
AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl4
Kanno, K., Tazuma, S., & Chayama, K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01357-3 · Cited by 74
Martinelli, A. D. L. C., Franco, R. F., Villanova, M. G., Figueiredo, J. F. C., Secaf, M., Tavella, M. H., Ramalho, L. N. Z., Zucoloto, S., & Zago, M. A. (1999) · Acta Haematologica · doi:10.1159/000040991 · Cited by 73
Suskind, D. L., & Muench, M. O. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.007 · Cited by 72
Chemokines in liver inflammation and fibrosis
Marra, F. (2002) · Frontiers in bioscience · doi:10.2741/marra · Cited by 69
III. Posttranscriptional regulation of type I collagen
Lindquist, J., Marzluff, W. F., & Stefanovic, B. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.3.g471 · Cited by 67
Hirata, M., Akbar, S. M. F., Horiike, N., & Onji, M. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00840.x · Cited by 60
Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis.
Ramalho, L. N. Z., Ramalho, F. S., Zucoloto, S., Júnior, O. C.-E.-S., Corrêa, F. M. D. A., Elías, J., & Magalhães, J. F. G. (2002) · PubMed · Cited by 56
Tuncer, İ., Özbek, H., Ugras, S. N., & Bayram, İ. (2003) · Experimental and Toxicologic Pathology · doi:10.1078/0940-2993-00309 · Cited by 55
Lindquist, J. N., Parsons, C. J., Stefanovic, B., & Brenner, D. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314060200 · Cited by 55
Self-citationBataller, R. A., Schwabe, R. F., Choi, Y. H., Liu, Y., Paik, Y. H., Lindquist, J. N., Qian, T., Schoonhoven, R., Hagedorn, C. H., Lemasters, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318212 · Cited by 54
Self-citationExperimental Models of Hepatic Fibrosis in the Rat
Wasser, S., & Tan, C. E. L. (1999) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v28n1p109 · Cited by 53
The potential role of genes in nonalcoholic fatty liver disease
Day, C. P. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.001 · Cited by 51
Boya, P., Larrea, E., Sola, I., Majano, P. L., Jiménez, C., Civeira, M.-P., & Prìeto, J. (2001) · Hepatology · doi:10.1053/jhep.2001.29002 · Cited by 49
Maher, J. J., Zia, S., & Tzagarakis, C. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00033.x · Cited by 49
Pinzani, M. (1999) · Springer Seminars in Immunopathology · doi:10.1007/bf00870306 · Cited by 47
Soyer, M. T., Ceballos, R., & ALDRETE, J. S. (1976) · PubMed · Cited by 44
Pinzani, M. (2000) · Springer Seminars in Immunopathology · doi:10.1007/s002810000037 · Cited by 37
Akuta, N., Chayama, K., Suzuki, F., Someya, T., Kobayashi, M., Tsubota, A., Suzuki, Y., Saitoh, S., Arase, Y., Ikeda, K., et al. (2001) · Journal of Medical Virology · doi:10.1002/jmv.1025 · Cited by 33
Schaffner, F., & Klion, F. M. (1968) · Annual Review of Medicine · doi:10.1146/annurev.me.19.020168.000325 · Cited by 30
Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?
Corpechot, C., Benlian, P., Barbu, V., Chazouillères, O., Poupon, R. E., & Poupon, R. Y. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00137-4 · Cited by 27
Isolation of a Lipocyte-Rich Fraction from Rat Liver Nonparenchymal Cells
Otto, D. A., & Veech, R. L. (1980) · Springer eBooks · doi:10.1007/978-1-4757-1419-7_52 · Cited by 16
Flagged first, then by citations
Research works printed but not linked: 9
- Soyer, 1976, Surgery., 79, 601
- Otto, 1980, Adv. Exp. Med. Biol., 132, 509
- Wasser, 1999, Ann. Acad. Med. Singapore., 28, 109
- Brunt, 2004, Semin. Liver Dis., 24, 3
- Phillips, 2004, J. Clin. Invest., 114, 438, 10.1172/jci200420997 · DOI
- Kmiec, 2001, Adv. Anat. Embryol. Cell Biol., 161, III–XIII, 1–151
- Thurman, 1998, Am. J. Physiol., 275, G605
- Wei, 2000, World J. Gastroenterol., 6, 540
- Tuncer, 2003, Exp. Toxicol. Pathol., 55, 159
Cited by
Sorted by citations
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El‐Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,484
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Metadata
- Authors
- Bataller, R., & Brenner, D. A.
- Affiliations
- Columbia University (US)
- Corresponding author
- Brenner, David A.
- ORCID
- Brenner, David A.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-02-01
- Volume
- 115
- Issue
- 2
- Pages
- 209-218
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4255712601
- Cited by
- 4,958
- References
- 134
- Citations by year
- 2026: 177 · 2025: 236 · 2024: 285 · 2023: 289 · 2022: 307 · 2021: 321 · 2020: 294 · 2019: 275 · 2018: 284 · 2017: 295 · 2016: 281 · 2015: 307 · 2014: 229 · 2013: 224 · 2012: 222
- FWCI
- 17.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministerio de Ciencia y Tecnología
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- liver fibrosis, extracellular matrix accumulation, collagen deposition, chronic liver disease, liver cirrhosis, hepatic stellate cells, portal fibroblasts, myofibroblasts, TGF-β1, angiotensin II, leptin, fibrogenic cytokines, antifibrotic agents, fibrosis pathogenesis, fibrosis diagnosis, liver transplantation
- MeSH terms
- Angiotensin II, Animals, Humans, Hypertension, Portal, Liver Cirrhosis, Transforming Growth Factor beta, Liver Failure, Leptin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review